Zhuhai Rundu Pharmaceutical Co Ltd Class A (002923) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.036x

Based on the latest financial reports, Zhuhai Rundu Pharmaceutical Co Ltd Class A (002923) has a cash flow conversion efficiency ratio of 0.036x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥37.78 Million ≈ $5.53 Million USD) by net assets (CN¥1.05 Billion ≈ $153.24 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Zhuhai Rundu Pharmaceutical Co Ltd Class A - Cash Flow Conversion Efficiency Trend (2011–2024)

This chart illustrates how Zhuhai Rundu Pharmaceutical Co Ltd Class A's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Zhuhai Rundu Pharmaceutical Co Ltd Class (002923) financial obligations for a breakdown of total debt and financial obligations.

Zhuhai Rundu Pharmaceutical Co Ltd Class A Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Zhuhai Rundu Pharmaceutical Co Ltd Class A ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Shenzhen Longli Technology Co Ltd Class A SHE:300752	0.019x
Shandong Liancheng Precision Manufacturing Co Ltd Class A SHE:002921	0.005x
Tsakos Energy Navigation Limited F:TK41	0.046x
SK Discovery Co Ltd KO:006120	0.030x
Lindian Resources Ltd AU:LIN	-0.046x
Hektas Ticaret TAS IS:HEKTS	0.024x
Tiptree Inc NASDAQ:TIPT	0.183x
Alerus Financial Corp NASDAQ:ALRS	0.041x

Annual Cash Flow Conversion Efficiency for Zhuhai Rundu Pharmaceutical Co Ltd Class A (2011–2024)

The table below shows the annual cash flow conversion efficiency of Zhuhai Rundu Pharmaceutical Co Ltd Class A from 2011 to 2024. For the full company profile with market capitalisation and key ratios, see Zhuhai Rundu Pharmaceutical Co Ltd Class (002923) total market value.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥1.15 Billion ≈ $168.59 Million	CN¥211.19 Million ≈ $30.90 Million	0.183x	+25.17%
2023-12-31	CN¥1.18 Billion ≈ $172.55 Million	CN¥172.68 Million ≈ $25.27 Million	0.146x	+29.73%
2022-12-31	CN¥1.20 Billion ≈ $175.01 Million	CN¥135.01 Million ≈ $19.76 Million	0.113x	-39.03%
2021-12-31	CN¥1.11 Billion ≈ $162.74 Million	CN¥205.91 Million ≈ $30.13 Million	0.185x	-23.22%
2020-12-31	CN¥1.04 Billion ≈ $151.93 Million	CN¥250.35 Million ≈ $36.63 Million	0.241x	+49.86%
2019-12-31	CN¥940.29 Million ≈ $137.59 Million	CN¥151.30 Million ≈ $22.14 Million	0.161x	-11.85%
2018-12-31	CN¥871.29 Million ≈ $127.50 Million	CN¥159.04 Million ≈ $23.27 Million	0.183x	+53.97%
2017-12-31	CN¥488.84 Million ≈ $71.53 Million	CN¥57.95 Million ≈ $8.48 Million	0.119x	-49.82%
2016-12-31	CN¥398.19 Million ≈ $58.27 Million	CN¥94.07 Million ≈ $13.77 Million	0.236x	+46.41%
2015-12-31	CN¥310.72 Million ≈ $45.47 Million	CN¥50.14 Million ≈ $7.34 Million	0.161x	-23.98%
2014-12-31	CN¥273.31 Million ≈ $39.99 Million	CN¥58.01 Million ≈ $8.49 Million	0.212x	+58.34%
2013-12-31	CN¥236.29 Million ≈ $34.58 Million	CN¥31.67 Million ≈ $4.63 Million	0.134x	-61.82%
2012-12-31	CN¥199.43 Million ≈ $29.18 Million	CN¥70.01 Million ≈ $10.25 Million	0.351x	+72.18%
2011-12-31	CN¥165.33 Million ≈ $24.19 Million	CN¥33.71 Million ≈ $4.93 Million	0.204x	--

About Zhuhai Rundu Pharmaceutical Co Ltd Class A

SHE:002923 China Drug Manufacturers - Specialty & Generic

Market Cap

$647.85 Million

CN¥4.43 Billion CNY

Market Cap Rank

#11225 Global

#3360 in China

Share Price

CN¥13.22

Change (1 day)

-0.45%

52-Week Range

CN¥11.97 - CN¥17.35

All Time High

CN¥20.52